PMC10174458_01
The timeline of patient's history.
fsurg-10-1115181-g001.jpg
PMC10174458_01_fsurg-10-1115181-g001.jpg
F1
In the meantime he took Sorafenib for one year. (Figure 1).
(A) computed tomography (CT) depicted a gallbladder tumor with dimensions of 8 x 4 cm. (B) Coronal image shows a clear demarcation between the tumor and the adjacent liver parenchyma. (C) No perceivable intrahepatic foci were found. (D) The right portal vein is tumor thrombus free.
fsurg-10-1115181-g002.jpg
PMC10174458_01_fsurg-10-1115181-g002.jpg
F2
This gallbladder tumor showed punctate enhancement in the hepatic arterial phase and then became less dense than the liver parenchyma in the portal phase (Figure 2).
(A) macroscopic examination shows that the gallbladder lumen is filled with white fish-like tissue. (B) Histopathological examination revealed moderately differentiated hepatocellular carcinoma cells (hematoxylin and eosin, x 100).
fsurg-10-1115181-g003.jpg
PMC10174458_01_fsurg-10-1115181-g003.jpg
F3
Macroscopically the diseased gallbladder appeared to be filled with white soft tumor tissue, and some tissue had extended along the cystic duct to the common bile duct (Figure 3A). The postoperative paraffin histopathology and immunohistochemistry showed a moderately differentiated HCC with necrosis (Figure 3B).